Golimumab

Details

Files

Generic Name:

Golimumab

Project Status:

Complete

Therapeutic Area:

Arthritis, rheumatoid

Manufacturer:

Janssen Inc.

Call for patient/clinician input open:

September 13, 2013

Brand Name:

Simponi I.V.

Project Line:

Reimbursement Review

Project Number:

SR0351-000

Call for patient/clinician input closed:

October 4, 2013

NOC Status at Filing:

Pre NOC

Performance Metric:

N/A — Predated performance metrics

Submission Type:

Initial

Indications:

Arthritis, Rheumatoid

Recommendation Type:

List with criteria/condition

Final Recommendation:

July 17, 2014

Files

Submission Status Report View PDF

Recommendation and Reasons View PDF

Clinical Report View PDF

Pharmacoeconomic Report View PDF

Last Updated : September 12, 2013